SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
Year-over-year operating income growth rate
Percentile
P15
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -12.29% |
| Q3 2025 | 29.47% |
| Q2 2025 | -7.93% |
| Q1 2025 | 31.22% |
| Q4 2024 | 7.31% |
| Q3 2024 | -9.09% |
| Q2 2024 | -6.67% |
| Q1 2024 | 28.28% |
| Q4 2023 | 1.24% |
| Q3 2023 | 9.08% |
| Q2 2023 | 18.20% |
| Q1 2023 | 27.57% |
| Q4 2022 | 107.21% |
| Q3 2022 | 169.57% |
| Q2 2022 | 28.21% |
| Q1 2022 | -164.27% |
| Q4 2021 | -51.04% |
| Q3 2021 | 6.21% |
| Q2 2021 | 2.41% |
| Q1 2021 | 23.42% |
| Q4 2020 | 59.68% |
| Q3 2020 | 13.23% |
| Q2 2020 | 86.06% |
| Q1 2020 | -41.44% |
| Q4 2019 | -13.05% |
| Q3 2019 | -7.02% |
| Q2 2019 | 70.06% |
| Q1 2019 | -48.74% |
| Q4 2018 | 1.27% |
| Q3 2018 | 8.21% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q3 2016 | 25.25% |
| Q2 2016 | 1.62% |
| Q1 2016 | -17.57% |
| Q4 2015 | 20.69% |